Browse by Changes
Summary of Changes – 1 January 2023
Page last updated: 1 January 2023
Previous versions of the Summary of Changes are available in PDF in the Publications Archive.
- Prescriber Bag
- Additions
- Deletions
- Alterations
- Supply Only
- Advance Notices
- Palliative Care
- Highly Specialised Drugs Program (Private Hospital)
- Highly Specialised Drugs Program (Public Hospital)
- Repatriation Pharmaceutical Benefits
- Efficient Funding of Chemotherapy (Private Hospital)
- Efficient Funding of Chemotherapy (Public Hospital)
- Related Pharmaceutical Benefits for Public Hospital use
Prescriber Bag
Advance Notices
1 February 2023
Deletion – Brand
3497C | APO-Salbutamol, TX – SALBUTAMOL, salbutamol 5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules |
1 April 2023
Deletion – Brand
3479D | DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 15 mg/mL injection, 5 x 1 mL ampoules |
3480E | DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 30 mg/mL injection, 5 x 1 mL ampoules |
General Pharmaceutical Benefits
Additions
Addition – Item
13200R | BECLOMETASONE + FORMOTEROL (EFORMOTEROL) + GLYCOPYRRONIUM, beclometasone dipropionate 200 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 120 actuations (Trimbow) |
13199Q | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
13202W | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
13177M | FARICIMAB, faricimab 28.8 mg/0.24 mL injection, 0.24 mL vial (Vabysmo) |
13183W | FARICIMAB, faricimab 28.8 mg/0.24 mL injection, 0.24 mL vial (Vabysmo) |
13195L | FARICIMAB, faricimab 28.8 mg/0.24 mL injection, 0.24 mL vial (Vabysmo) |
13198P | FARICIMAB, faricimab 28.8 mg/0.24 mL injection, 0.24 mL vial (Vabysmo) |
11049M | SODIUM CHLORIDE + POTASSIUM CHLORIDE + GLUCOSE MONOHYDRATE + CITRIC ACID, sodium chloride 470 mg + potassium chloride 300 mg (potassium 4 mmol) + glucose monohydrate 3.56 g + sodium acid citrate 530 mg powder for oral liquid, 10 x 4.9 g sachets (O.R.S.) |
Addition – Brand
5542Q | Vizo-PF Dorzolatim, AE – DORZOLAMIDE + TIMOLOL, dorzolamide 2% + timolol 0.5% eye drops, 5 mL |
8567X | Vizo-PF Dorzolatim, AE – DORZOLAMIDE + TIMOLOL, dorzolamide 2% + timolol 0.5% eye drops, 5 mL |
9432K | Escitalopram Sandoz, HX – ESCITALOPRAM, escitalopram 10 mg tablet, 28 |
9433L | Escitalopram Sandoz, HX – ESCITALOPRAM, escitalopram 20 mg tablet, 28 |
8651H | Pharmacor Mycophenolate, CR – MYCOPHENOLATE, mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL |
10004M | Sunitinib MSN, LR – SUNITINIB, sunitinib 12.5 mg capsule, 28 |
10009T | Sunitinib MSN, LR – SUNITINIB, sunitinib 12.5 mg capsule, 28 |
11266Y | Sunitinib MSN, LR – SUNITINIB, sunitinib 12.5 mg capsule, 28 |
9417P | Sunitinib MSN, LR – SUNITINIB, sunitinib 12.5 mg capsule, 28 |
9420T | Sunitinib MSN, LR – SUNITINIB, sunitinib 12.5 mg capsule, 28 |
9488J | Sunitinib MSN, LR – SUNITINIB, sunitinib 12.5 mg capsule, 28 |
11253G | Sunitinib MSN, LR – SUNITINIB, sunitinib 25 mg capsule, 28 |
2842N | Sunitinib MSN, LR – SUNITINIB, sunitinib 25 mg capsule, 28 |
2959R | Sunitinib MSN, LR – SUNITINIB, sunitinib 25 mg capsule, 28 |
9418Q | Sunitinib MSN, LR – SUNITINIB, sunitinib 25 mg capsule, 28 |
9421W | Sunitinib MSN, LR – SUNITINIB, sunitinib 25 mg capsule, 28 |
9489K | Sunitinib MSN, LR – SUNITINIB, sunitinib 25 mg capsule, 28 |
10459L | Sunitinib MSN, LR – SUNITINIB, sunitinib 37.5 mg capsule, 28 |
10464R | Sunitinib MSN, LR – SUNITINIB, sunitinib 37.5 mg capsule, 28 |
10473F | Sunitinib MSN, LR – SUNITINIB, sunitinib 37.5 mg capsule, 28 |
10503T | Sunitinib MSN, LR – SUNITINIB, sunitinib 37.5 mg capsule, 28 |
10504W | Sunitinib MSN, LR – SUNITINIB, sunitinib 37.5 mg capsule, 28 |
11256K | Sunitinib MSN, LR – SUNITINIB, sunitinib 37.5 mg capsule, 28 |
10010W | Sunitinib MSN, LR – SUNITINIB, sunitinib 50 mg capsule, 28 |
11250D | Sunitinib MSN, LR – SUNITINIB, sunitinib 50 mg capsule, 28 |
2837H | Sunitinib MSN, LR – SUNITINIB, sunitinib 50 mg capsule, 28 |
9419R | Sunitinib MSN, LR – SUNITINIB, sunitinib 50 mg capsule, 28 |
9422X | Sunitinib MSN, LR – SUNITINIB, sunitinib 50 mg capsule, 28 |
9490L | Sunitinib MSN, LR – SUNITINIB, sunitinib 50 mg capsule, 28 |
Addition – Equivalence Indicator
8651H | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL |
Addition – Note
12910L | MOLNUPIRAVIR, molnupiravir 200 mg capsule, 40 (Lagevrio) |
Deletions
Deletion – Brand
8245Y | Fera, AS – LETROZOLE, letrozole 2.5 mg tablet, 30 |
1746X | Mendeleev Paracetamol, HX – PARACETAMOL, paracetamol 500 mg tablet, 100 |
5196L | Mendeleev Paracetamol, HX – PARACETAMOL, paracetamol 500 mg tablet, 100 |
5224Y | Mendeleev Paracetamol, HX – PARACETAMOL, paracetamol 500 mg tablet, 100 |
8784H | Mendeleev Paracetamol, HX – PARACETAMOL, paracetamol 500 mg tablet, 100 |
12001P | Biaxsig, AV – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10 |
12001P | Rulide, SW – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10 |
1760P | Biaxsig, AV – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10 |
1760P | Rulide, SW – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10 |
5260W | Biaxsig, AV – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10 |
5260W | Rulide, SW – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10 |
11993F | Biaxsig, AV – ROXITHROMYCIN, roxithromycin 300 mg tablet, 5 |
5261X | Biaxsig, AV – ROXITHROMYCIN, roxithromycin 300 mg tablet, 5 |
8016X | Biaxsig, AV – ROXITHROMYCIN, roxithromycin 300 mg tablet, 5 |
Deletion – Note
2856H | PHENELZINE, phenelzine 15 mg tablet, 100 (Nardil) |
Alterations
Alteration – Restriction
12667Q | BROLUCIZUMAB, brolucizumab 6 mg/0.05 mL intraocular injection, 0.05 mL syringe (Beovu) |
12683M | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
5449T | LEFLUNOMIDE, leflunomide 10 mg tablet, 30 (Arabloc, Arava, Ataris 10, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth) |
8374R | LEFLUNOMIDE, leflunomide 10 mg tablet, 30 (Arabloc, Arava, Ataris 10, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth, Lunava 10) |
5450W | LEFLUNOMIDE, leflunomide 20 mg tablet, 30 (Arava, Ataris 20, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth) |
8375T | LEFLUNOMIDE, leflunomide 20 mg tablet, 30 (Arava, Ataris 20, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth, Lunava 20) |
12910L | MOLNUPIRAVIR, molnupiravir 200 mg capsule, 40 (Lagevrio) |
12996B | NIRMATRELVIR (&) RITONAVIR, nirmatrelvir 150 mg tablet [4] (&) ritonavir 100 mg tablet [2], 5 x 6 (Paxlovid) |
Alteration – Restriction Level
From | To | ||
5449T | LEFLUNOMIDE, leflunomide 10 mg tablet, 30 (Arabloc, Arava, Ataris 10, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth) | streamlined | restricted |
8374R | LEFLUNOMIDE, leflunomide 10 mg tablet, 30 (Arabloc, Arava, Ataris 10, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth, Lunava 10) | streamlined | restricted |
5450W | LEFLUNOMIDE, leflunomide 20 mg tablet, 30 (Arava, Ataris 20, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth) | streamlined | restricted |
8375T | LEFLUNOMIDE, leflunomide 20 mg tablet, 30 (Arava, Ataris 20, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth, Lunava 20) | streamlined | restricted |
Alteration – Manufacturer Code
From | To | ||
8179L | Anastrol – ANASTROZOLE, anastrozole 1 mg tablet, 30 | AS | TB |
Supply Only
When a product is deleted from the Schedule it may be available under Supply Only rules. Supply Only items/brands are available on the Schedule for dispensing but not for prescribing, usually for a period of up to 12 months from when it is deleted.
Substitution of Supply Only items/brands with products flagged as “equivalent for substitution” still apply as specified in the Schedule at the time the script was written.
Further information on Supply Only arrangements is available at www.pbs.gov.au
Supply Only Commencing 1 January 2023
11564P | ERTUGLIFLOZIN + METFORMIN, ertugliflozin 2.5 mg + metformin hydrochloride 1 g tablet, 56 (Segluromet 2.5/1000) |
11581M | ERTUGLIFLOZIN + METFORMIN, ertugliflozin 2.5 mg + metformin hydrochloride 1 g tablet, 56 (Segluromet 2.5/1000) |
11575F | ERTUGLIFLOZIN + METFORMIN, ertugliflozin 2.5 mg + metformin hydrochloride 500 mg tablet, 56 (Segluromet 2.5/500) |
11584Q | ERTUGLIFLOZIN + METFORMIN, ertugliflozin 2.5 mg + metformin hydrochloride 500 mg tablet, 56 (Segluromet 2.5/500) |
11563N | ERTUGLIFLOZIN + METFORMIN, ertugliflozin 7.5 mg + metformin hydrochloride 1 g tablet, 56 (Segluromet 7.5/1000) |
11569X | ERTUGLIFLOZIN + METFORMIN, ertugliflozin 7.5 mg + metformin hydrochloride 1 g tablet, 56 (Segluromet 7.5/1000) |
11562M | ERTUGLIFLOZIN + METFORMIN, ertugliflozin 7.5 mg + metformin hydrochloride 500 mg tablet, 56 (Segluromet 7.5/500) |
11568W | ERTUGLIFLOZIN + METFORMIN, ertugliflozin 7.5 mg + metformin hydrochloride 500 mg tablet, 56 (Segluromet 7.5/500) |
Advance Notices
1 February 2023
Deletion – Brand
3423E | Byetta 5 microgram, AP – EXENATIDE, exenatide 5 microgram/0.02 mL injection, 1.2 mL pen device |
3424F | Byetta 10 microgram, AP – EXENATIDE, exenatide 10 microgram/0.04 mL injection, 2.4 mL pen device |
1692C | ARX-Nitrofurantoin, XT – NITROFURANTOIN, nitrofurantoin 50 mg capsule, 30 |
1693D | ARX-Nitrofurantoin, XT – NITROFURANTOIN, nitrofurantoin 100 mg capsule, 30 |
2001H | APO-Salbutamol, TX – SALBUTAMOL, salbutamol 5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules |
8885P | Imigran FDT, AS – SUMATRIPTAN, SUMATRIPTAN Tablet (fast disintegrating) 50 mg (as succinate), 2 |
1 March 2023
Deletion – Brand
1750D | Ircal, PE – PARAFFIN, paraffin 1 g/g eye ointment, 2 x 3.5 g |
5522P | Ircal, PE – PARAFFIN, paraffin 1 g/g eye ointment, 2 x 3.5 g |
9218E | Ircal, PE – PARAFFIN, paraffin 1 g/g eye ointment, 2 x 3.5 g |
1897W | Feldene, PF – PIROXICAM, piroxicam 10 mg capsule, 50 |
5203W | Feldene, PF – PIROXICAM, piroxicam 10 mg capsule, 50 |
1 April 2023
Deletion – Brand
9092M | Strattera, LY – ATOMOXETINE, atomoxetine 10 mg capsule, 28 |
9093N | Strattera, LY – ATOMOXETINE, atomoxetine 18 mg capsule, 28 |
9094P | Strattera, LY – ATOMOXETINE, atomoxetine 25 mg capsule, 28 |
9095Q | Strattera, LY – ATOMOXETINE, atomoxetine 40 mg capsule, 28 |
9096R | Strattera, LY – ATOMOXETINE, atomoxetine 60 mg capsule, 28 |
9289X | Strattera, LY – ATOMOXETINE, atomoxetine 80 mg capsule, 28 |
9290Y | Strattera, LY – ATOMOXETINE, atomoxetine 100 mg capsule, 28 |
9299K | Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 4 mg modified release tablet, 14 |
9406C | Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 8 mg modified release tablet, 14 |
9407D | Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 16 mg modified release tablet, 14 |
9408E | Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 32 mg modified release tablet, 14 |
9409F | Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 64 mg modified release tablet, 14 |
2436F | Natrilix, SE – INDAPAMIDE, indapamide hemihydrate 2.5 mg tablet, 90 |
8196J | Sporanox, JC – ITRACONAZOLE, itraconazole 100 mg capsule, 60 |
1644M | DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 10 mg/mL injection, 5 x 1 mL ampoules |
1645N | DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 15 mg/mL injection, 5 x 1 mL ampoules |
1647Q | DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 30 mg/mL injection, 5 x 1 mL ampoules |
5168B | DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 10 mg/mL injection, 5 x 1 mL ampoules |
5169C | DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 15 mg/mL injection, 5 x 1 mL ampoules |
5170D | DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 30 mg/mL injection, 5 x 1 mL ampoules |
1 August 2023
Deletion – Brand
2418G | Amitriptyline Alphapharm 25, MQ – AMITRIPTYLINE, amitriptyline hydrochloride 25 mg tablet, 50 |
1358L | Dosulepin Mylan, MQ – DOSULEPIN (DOTHIEPIN), dosulepin (dothiepin) hydrochloride 75 mg tablet, 30 |
1500Y | Hydrocortisone Mylan 20, MQ – HYDROCORTISONE, hydrocortisone 20 mg tablet, 60 |
Palliative Care
Advance Notices
1 April 2023
Deletion – Brand
12473L | Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 16 mg modified release tablet, 14 |
12482Y | Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 8 mg modified release tablet, 14 |
12496Q | Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 4 mg modified release tablet, 14 |
12535R | Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 64 mg modified release tablet, 14 |
12543E | Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 32 mg modified release tablet, 14 |
12499W | DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 10 mg/mL injection, 5 x 1 mL ampoules |
12503C | DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 30 mg/mL injection, 5 x 1 mL ampoules |
12548K | DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 15 mg/mL injection, 5 x 1 mL ampoules |
Highly Specialised Drugs Program (Private Hospital)
Additions
Addition – Brand
6364Y | Pharmacor Mycophenolate, CR – MYCOPHENOLATE, mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL |
6371H | Zoledronic Acid Accord, OC – ZOLEDRONIC ACID, zoledronic acid 4 mg/5 mL injection, 5 mL vial |
Addition – Equivalence Indicator
6364Y | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL |
Addition – Note
10417G | POMALIDOMIDE, pomalidomide 3 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
12668R | POMALIDOMIDE, pomalidomide 3 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
10386P | POMALIDOMIDE, pomalidomide 4 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
12661J | POMALIDOMIDE, pomalidomide 4 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
Deletions
Deletion – Equivalence Indicator
10417G | Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 3 mg capsule, 21 |
10417G | Pomalyst, CJ – POMALIDOMIDE, pomalidomide 3 mg capsule, 21 |
10417G | Pomolide, JU – POMALIDOMIDE, pomalidomide 3 mg capsule, 21 |
12668R | Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 3 mg capsule, 14 |
12668R | Pomalyst, CJ – POMALIDOMIDE, pomalidomide 3 mg capsule, 14 |
12668R | Pomolide, JU – POMALIDOMIDE, pomalidomide 3 mg capsule, 14 |
10386P | Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 4 mg capsule, 21 |
10386P | Pomalyst, CJ – POMALIDOMIDE, pomalidomide 4 mg capsule, 21 |
10386P | Pomolide, JU – POMALIDOMIDE, pomalidomide 4 mg capsule, 21 |
12661J | Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 4 mg capsule, 14 |
12661J | Pomalyst, CJ – POMALIDOMIDE, pomalidomide 4 mg capsule, 14 |
12661J | Pomolide, JU – POMALIDOMIDE, pomalidomide 4 mg capsule, 14 |
Alterations
Alteration – Note
5827Q | ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade) |
5828R | ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade) |
9697J | ROMIPLOSTIM, romiplostim 250 microgram injection, 1 vial (Nplate) |
9699L | ROMIPLOSTIM, romiplostim 500 microgram injection, 1 vial (Nplate) |
Alteration – Restriction
5827Q | ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade) |
5828R | ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade) |
10417G | POMALIDOMIDE, pomalidomide 3 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
12668R | POMALIDOMIDE, pomalidomide 3 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
10386P | POMALIDOMIDE, pomalidomide 4 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
12661J | POMALIDOMIDE, pomalidomide 4 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
9697J | ROMIPLOSTIM, romiplostim 250 microgram injection, 1 vial (Nplate) |
9699L | ROMIPLOSTIM, romiplostim 500 microgram injection, 1 vial (Nplate) |
Alteration – Number of Repeats
From | To | ||
9697J | ROMIPLOSTIM, romiplostim 250 microgram injection, 1 vial (Nplate) | 0 | 5 |
9699L | ROMIPLOSTIM, romiplostim 500 microgram injection, 1 vial (Nplate) | 0 | 5 |
Highly Specialised Drugs Program (Public Hospital)
Additions
Addition – Brand
9500B | Pharmacor Mycophenolate, CR – MYCOPHENOLATE, mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL |
9653C | Zoledronic Acid Accord, OC – ZOLEDRONIC ACID, zoledronic acid 4 mg/5 mL injection, 5 mL vial |
Addition – Equivalence Indicator
9500B | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL |
Addition – Note
10406Q | POMALIDOMIDE, pomalidomide 3 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
12666P | POMALIDOMIDE, pomalidomide 3 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
10387Q | POMALIDOMIDE, pomalidomide 4 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
12665N | POMALIDOMIDE, pomalidomide 4 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
Deletions
Deletion – Equivalence Indicator
10406Q | Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 3 mg capsule, 21 |
10406Q | Pomalyst, CJ – POMALIDOMIDE, pomalidomide 3 mg capsule, 21 |
10406Q | Pomolide, JU – POMALIDOMIDE, pomalidomide 3 mg capsule, 21 |
12666P | Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 3 mg capsule, 14 |
12666P | Pomalyst, CJ – POMALIDOMIDE, pomalidomide 3 mg capsule, 14 |
12666P | Pomolide, JU – POMALIDOMIDE, pomalidomide 3 mg capsule, 14 |
10387Q | Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 4 mg capsule, 21 |
10387Q | Pomalyst, CJ – POMALIDOMIDE, pomalidomide 4 mg capsule, 21 |
10387Q | Pomolide, JU – POMALIDOMIDE, pomalidomide 4 mg capsule, 21 |
12665N | Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 4 mg capsule, 14 |
12665N | Pomalyst, CJ – POMALIDOMIDE, pomalidomide 4 mg capsule, 14 |
12665N | Pomolide, JU – POMALIDOMIDE, pomalidomide 4 mg capsule, 14 |
Alterations
Alteration – Note
5825N | ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade) |
5826P | ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade) |
9696H | ROMIPLOSTIM, romiplostim 250 microgram injection, 1 vial (Nplate) |
9698K | ROMIPLOSTIM, romiplostim 500 microgram injection, 1 vial (Nplate) |
Alteration – Restriction
5825N | ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade) |
5826P | ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade) |
10406Q | POMALIDOMIDE, pomalidomide 3 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
12666P | POMALIDOMIDE, pomalidomide 3 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
10387Q | POMALIDOMIDE, pomalidomide 4 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
12665N | POMALIDOMIDE, pomalidomide 4 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide) |
9696H | ROMIPLOSTIM, romiplostim 250 microgram injection, 1 vial (Nplate) |
9698K | ROMIPLOSTIM, romiplostim 500 microgram injection, 1 vial (Nplate) |
Alteration – Number of Repeats
From | To | ||
9696H | ROMIPLOSTIM, romiplostim 250 microgram injection, 1 vial (Nplate) | 0 | 5 |
9698K | ROMIPLOSTIM, romiplostim 500 microgram injection, 1 vial (Nplate) | 0 | 5 |
Repatriation Pharmaceutical Benefits
Deletions
Deletion – Brand
10582Y | Mendeleev Paracetamol, HX – PARACETAMOL, paracetamol 500 mg tablet, 100 |
10585D | Mendeleev Paracetamol, HX – PARACETAMOL, paracetamol 500 mg tablet, 100 |
Efficient Funding of Chemotherapy (Private Hospital)
Additions
Addition – Restriction
12219D |
BORTEZOMIB, bortezomib 1 mg injection, 1 vial (Bortezomib Accord); bortezomib 1 mg injection, 1 vial (Bortezomib Juno); bortezomib 1 mg injection, 1 vial (DBL Bortezomib); bortezomib 1 mg injection, 1 vial (Velcade); bortezomib 2.5 mg injection, 1 vial (Bortezomib Juno); bortezomib 2.5 mg injection, 1 vial (DBL Bortezomib); bortezomib 3 mg injection, 1 vial (DBL Bortezomib); bortezomib 3 mg injection, 1 vial (Velcade); bortezomib 3.5 mg injection, 1 vial (Bortezom); bortezomib 3.5 mg injection, 1 vial (Bortezomib Accord); bortezomib 3.5 mg injection, 1 vial (Bortezomib Baxter); bortezomib 3.5 mg injection, 1 vial (Bortezomib Juno); bortezomib 3.5 mg injection, 1 vial (Bortezomib Sandoz); bortezomib 3.5 mg injection, 1 vial (Bortezomib-AFT); bortezomib 3.5 mg injection, 1 vial (Bortezomib-Dr.Reddy's); bortezomib 3.5 mg injection, 1 vial (BORTEZOMIB-TEVA); bortezomib 3.5 mg injection, 1 vial (DBL Bortezomib); bortezomib 3.5 mg injection, 1 vial (Velcade); bortezomib 2.5 mg/mL injection, 1 mL vial (Bortezomib Accord); bortezomib 2.5 mg/mL injection, 1 mL vial (Bortezomib Ever Pharma); bortezomib 3.5 mg/1.4 mL injection, 1.4 mL vial (Bortezomib Accord); bortezomib 3.5 mg/1.4 mL injection, 1.4 mL vial (Bortezomib Ever Pharma) |
Deletions
Deletion – Brand
7249M | Irinotecan Kabi, PK – IRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
7254T | Paclitaxel Kabi, PK – PACLITAXEL, paclitaxel 30 mg/5 mL injection, 5 mL vial |
7254T | Paclitaxel Kabi, PK – PACLITAXEL, paclitaxel 300 mg/50 mL injection, 50 mL vial |
Alterations
Alteration – Restriction
13160P |
CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
12230Q |
DARATUMUMAB, daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex); daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex) |
7230M |
DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL), doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Caelyx); doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Liposomal Doxorubicin SUN); doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Caelyx); doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Liposomal Doxorubicin SUN) |
Alteration – Restriction Level
From | To | ||
7230M |
DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL), doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Caelyx); doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Liposomal Doxorubicin SUN); doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Caelyx); doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Liposomal Doxorubicin SUN) |
streamlined | unrestricted |
Efficient Funding of Chemotherapy (Public Hospital)
Additions
Addition – Restriction
12227M |
BORTEZOMIB, bortezomib 1 mg injection, 1 vial (Bortezomib Accord); bortezomib 1 mg injection, 1 vial (Bortezomib Juno); bortezomib 1 mg injection, 1 vial (DBL Bortezomib); bortezomib 1 mg injection, 1 vial (Velcade); bortezomib 2.5 mg injection, 1 vial (Bortezomib Juno); bortezomib 2.5 mg injection, 1 vial (DBL Bortezomib); bortezomib 3 mg injection, 1 vial (DBL Bortezomib); bortezomib 3 mg injection, 1 vial (Velcade); bortezomib 3.5 mg injection, 1 vial (Bortezom); bortezomib 3.5 mg injection, 1 vial (Bortezomib Accord); bortezomib 3.5 mg injection, 1 vial (Bortezomib Baxter); bortezomib 3.5 mg injection, 1 vial (Bortezomib Juno); bortezomib 3.5 mg injection, 1 vial (Bortezomib Sandoz); bortezomib 3.5 mg injection, 1 vial (Bortezomib-AFT); bortezomib 3.5 mg injection, 1 vial (Bortezomib-Dr.Reddy's); bortezomib 3.5 mg injection, 1 vial (BORTEZOMIB-TEVA); bortezomib 3.5 mg injection, 1 vial (DBL Bortezomib); bortezomib 3.5 mg injection, 1 vial (Velcade); bortezomib 2.5 mg/mL injection, 1 mL vial (Bortezomib Accord); bortezomib 2.5 mg/mL injection, 1 mL vial (Bortezomib Ever Pharma); bortezomib 3.5 mg/1.4 mL injection, 1.4 mL vial (Bortezomib Accord); bortezomib 3.5 mg/1.4 mL injection, 1.4 mL vial (Bortezomib Ever Pharma) |
Deletions
Deletion – Brand
4451G | Irinotecan Kabi, PK – IRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
4567J | Paclitaxel Kabi, PK – PACLITAXEL, paclitaxel 30 mg/5 mL injection, 5 mL vial |
4567J | Paclitaxel Kabi, PK – PACLITAXEL, paclitaxel 300 mg/50 mL injection, 50 mL vial |
Alterations
Alteration – Restriction
13169D |
CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
12228N |
DARATUMUMAB, daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex); daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex) |
4364Q |
DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL), doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Caelyx); doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Liposomal Doxorubicin SUN); doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Caelyx); doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Liposomal Doxorubicin SUN) |
Alteration – Restriction Level
From | To | ||
4364Q |
DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL), doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Caelyx); doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Liposomal Doxorubicin SUN); doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Caelyx); doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Liposomal Doxorubicin SUN) |
streamlined | unrestricted |
Related Pharmaceutical Benefits for Public Hospital use
Additions
Addition – Item
13201T | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
13203X | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
Alterations
Alteration – Restriction
12746W | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |